Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymol Effects on Netrin-1 in Obese Patients
NCT05427721Phase 2Unknown
- Sponsor
- Centro Universitario de Ciencias de la Salud
- Start
- Apr 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity comparing Thymol with Placebo (2 arms). Primary endpoint: Serum Netrin-1 Concentration at 90 days. Status: unknown.
02
Drugs
thymol
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05427721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05427721.